PURPOSE: A prototype of the hyperthermia treatment planning system (HTPS) HyperPlan for the SIGMA-60 applicator (BSD Medical Corp., Salt Lake City, Utah, USA) has been evaluated with respect to clinical practicability and correctness. MATERIALS AND METHODS: HyperPlan modules extract tissue boundaries from computed tomography (CT) images to generate regular and tetrahedral grids as patient models, to calculate electric field (E-field) distributions, and to visualize three-dimensional data sets. The finite difference time-domain (FDTD) method is applied to calculate the specific absorption rate (SAR) inside the patient. Temperature distributions are calculated by a finite-element code and can be optimized. HyperPlan was tested on 6 patients with pelvic tumors. For verification, measured SAR values were compared with calculated SAR values. Furthermore, intracorporeal E-field scans were performed and compared with calculated profiles. RESULTS: The HTPS can be applied under clinical conditions. Measured absolute SAR (in W/kg), as well as relative E-field scans, correlated well with calculated values (+/-20%) using the contour-based FDTD method. Values calculated by applying the FDTD method directly on the voxel (CT) grid, were less well correlated with measured data. CONCLUSION: The HyperPlan system proved to be clinically feasible, and the results were quantitatively and qualitatively verified for the contour-based FDTD method.
PURPOSE: A prototype of the hyperthermia treatment planning system (HTPS) HyperPlan for the SIGMA-60 applicator (BSD Medical Corp., Salt Lake City, Utah, USA) has been evaluated with respect to clinical practicability and correctness. MATERIALS AND METHODS: HyperPlan modules extract tissue boundaries from computed tomography (CT) images to generate regular and tetrahedral grids as patient models, to calculate electric field (E-field) distributions, and to visualize three-dimensional data sets. The finite difference time-domain (FDTD) method is applied to calculate the specific absorption rate (SAR) inside the patient. Temperature distributions are calculated by a finite-element code and can be optimized. HyperPlan was tested on 6 patients with pelvic tumors. For verification, measured SAR values were compared with calculated SAR values. Furthermore, intracorporeal E-field scans were performed and compared with calculated profiles. RESULTS: The HTPS can be applied under clinical conditions. Measured absolute SAR (in W/kg), as well as relative E-field scans, correlated well with calculated values (+/-20%) using the contour-based FDTD method. Values calculated by applying the FDTD method directly on the voxel (CT) grid, were less well correlated with measured data. CONCLUSION: The HyperPlan system proved to be clinically feasible, and the results were quantitatively and qualitatively verified for the contour-based FDTD method.
Authors: Zhen Li; Martin Vogel; Paolo F Maccarini; Vadim Stakhursky; Brian J Soher; Oana I Craciunescu; Shiva Das; Omar A Arabe; Williams T Joines; Paul R Stauffer Journal: Int J Hyperthermia Date: 2010-11-11 Impact factor: 3.914
Authors: Zhipeng Cao; Sukhoon Oh; Ricardo Otazo; Christopher T Sica; Mark A Griswold; Christopher M Collins Journal: Magn Reson Med Date: 2014-04-21 Impact factor: 4.668
Authors: Sukhoon Oh; Yeun-Chul Ryu; Giuseppe Carluccio; Christopher T Sica; Christopher M Collins Journal: Magn Reson Med Date: 2013-06-26 Impact factor: 4.668
Authors: Yu Yuan; Kung-Shan Cheng; Oana I Craciunescu; Paul R Stauffer; Paolo F Maccarini; Kavitha Arunachalam; Zeljko Vujaskovic; Mark W Dewhirst; Shiva K Das Journal: Med Phys Date: 2012-03 Impact factor: 4.071
Authors: Marianne Linthorst; Tomas Drizdal; Hans Joosten; Gerard C van Rhoon; Jacoba van der Zee Journal: Strahlenther Onkol Date: 2011-11-25 Impact factor: 3.621
Authors: H Petra Kok; Erik N K Cressman; Wim Ceelen; Christopher L Brace; Robert Ivkov; Holger Grüll; Gail Ter Haar; Peter Wust; Johannes Crezee Journal: Int J Hyperthermia Date: 2020 Impact factor: 3.914
Authors: Margarethus M Paulides; Paul R Stauffer; Esra Neufeld; Paolo F Maccarini; Adamos Kyriakou; Richard A M Canters; Chris J Diederich; Jurriaan F Bakker; Gerard C Van Rhoon Journal: Int J Hyperthermia Date: 2013-05-14 Impact factor: 3.914